Cargando…
Decision Support and Centralized Pharmacy Consultation for Nirmatrelvir-Ritonavir Prescribing in an Academic Health System—a Model to Promote Drug Access and Reduce Provider Burden
Autores principales: | Millstein, Jeffrey H., Asch, David A., Hamilton, Keith, Adusumalli, Srinath, Kasbekar, Nishaminy, Ahya, Vivek, Al-Ramahi, Nida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362507/ https://www.ncbi.nlm.nih.gov/pubmed/35922709 http://dx.doi.org/10.1007/s11606-022-07752-6 |
Ejemplares similares
-
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
por: Ratain, Mark J., et al.
Publicado: (2022) -
Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis
por: Savinkina, Alexandra, et al.
Publicado: (2022) -
Correction to: Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis
Publicado: (2023)